| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 11/07/2001 | EP1150996A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 11/07/2001 | EP1150995A1 A synthetic peptide disturbing intracellular signaling |
| 11/07/2001 | EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 11/07/2001 | EP1150982A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND I$g(k)-A$g(a) |
| 11/07/2001 | EP1150981A1 Therapeutic nucleoside compound |
| 11/07/2001 | EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors |
| 11/07/2001 | EP1150978A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 11/07/2001 | EP1150977A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 11/07/2001 | EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 11/07/2001 | EP1150972A1 Triazole and tetrazole derivatives, and their therapeutic use |
| 11/07/2001 | EP1150971A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 11/07/2001 | EP1150970A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 11/07/2001 | EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
| 11/07/2001 | EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 11/07/2001 | EP1150961A1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them |
| 11/07/2001 | EP1150960A1 Polymorphic crystalline forms of celecoxib |
| 11/07/2001 | EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability |
| 11/07/2001 | EP1150958A1 Substituted pyrazole carboxylic acids used to combat anaemias |
| 11/07/2001 | EP1150954A1 Anti-imflammatory indole derivatives |
| 11/07/2001 | EP1150952A1 Indole derivatives and their use as mcp-1 receptor antagonists |
| 11/07/2001 | EP1150951A1 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases |
| 11/07/2001 | EP1150950A2 Anthranilic acid derivatives |
| 11/07/2001 | EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 11/07/2001 | EP1150746A2 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 11/07/2001 | EP1150717A1 Sustained release salts of pharmaceutically active peptides and their production |
| 11/07/2001 | EP1150714A2 Methods for inhibiting brain tumor growth |
| 11/07/2001 | EP1150705A2 Protection of cells in connection with treatment with chemical agents |
| 11/07/2001 | EP1150697A1 High molecular weight extracts of convolvulus arvensis (field bindweed) |
| 11/07/2001 | EP1150695A2 Herbal supplement for increased muscle strength and endurance for athletes |
| 11/07/2001 | EP1150690A1 Chemical compounds |
| 11/07/2001 | EP1150689A1 Chemical compounds |
| 11/07/2001 | EP1150678A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 11/07/2001 | EP1150674A1 Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation |
| 11/07/2001 | EP1150670A2 Alkylating agents for treatment of cellular proliferation |
| 11/07/2001 | EP1150667A1 Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 11/07/2001 | EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease |
| 11/07/2001 | EP1150658A2 Method for controlling liposome size |
| 11/07/2001 | EP1011648B1 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 11/07/2001 | EP1003532B1 Lactobacilli to increase absorption of minerals by intestinal cells |
| 11/07/2001 | EP0980205A4 Method of treating malignancies |
| 11/07/2001 | EP0861235B1 Substituted benzylaminopiperidine compounds |
| 11/07/2001 | EP0848705B1 Crystalline r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 11/07/2001 | EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 11/07/2001 | EP0835108B1 Use of lamellarin-class alkaloids in methods of treatment |
| 11/07/2001 | EP0802917B1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
| 11/07/2001 | EP0777478B1 Inhibitors of rotamase enzyme activity |
| 11/07/2001 | EP0765152B1 Stimulation of hair growth by peptide-copper complexes |
| 11/07/2001 | EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 11/07/2001 | EP0600028B1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 11/07/2001 | EP0546108B1 Pro-drugs for cck antagonists |
| 11/07/2001 | CN1321159A Benzothieno [3,2-c]pyridines as alpha 2-antagonists |
| 11/07/2001 | CN1321158A Tricyclic delta 3-piperidines as pharmaceuticals |
| 11/07/2001 | CN1321157A Substd. imidazo [1,2] azines as selective inhibitors of COX-2 |
| 11/07/2001 | CN1321153A Telomerase inhibitors and method of their use |
| 11/07/2001 | CN1321150A Amide derivs. useful as inhibitors of production of cytokines |
| 11/07/2001 | CN1321087A MGluR 5 antagonists for treatment of pain and anxiety |
| 11/07/2001 | CN1320444A Medicine for treating neonatal jaundice |
| 11/07/2001 | CN1320443A Face-beautifying chewing gum and its preparing process |
| 11/07/2001 | CN1320441A Medicine containing active components of Panax japonicum root and preparing process thereof |
| 11/07/2001 | CN1320426A Compound for treatment of female sexual dysfuction |
| 11/07/2001 | CN1074412C Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivs. and medicines contg. same as active ingredient |
| 11/07/2001 | CN1074291C Medicinal ox horn |
| 11/07/2001 | CN1074284C Health-care tea with blood circulation promoting and blood pressure lowering effect, and method for preparing same |
| 11/06/2001 | USRE37438 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase |
| 11/06/2001 | US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants |
| 11/06/2001 | US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment |
| 11/06/2001 | US6313290 Azolobenzazepine derivatives and compositions and method of use thereof |
| 11/06/2001 | US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 11/06/2001 | US6313269 Tumor necrosis factor related receptor, TR6 |
| 11/06/2001 | US6313214 Melanin inhibiting and cell growth activating compositions containing compounds having labdane structure |
| 11/06/2001 | US6313180 Steroid compounds having contraceptive and anti-osteoporosis activity |
| 11/06/2001 | US6313175 For therapy of obesity; for quantitating the binding of serotonin or a serotonin ligand |
| 11/06/2001 | US6313172 Administering hydroxyethylthiourea derivative for therapy of pain in mammal |
| 11/06/2001 | US6313169 Lutein esters having high bioavailability |
| 11/06/2001 | US6313163 Administering 2,4-pentadienoic acid derivative for therapy of disease or condition responsive to therapy by retinoids |
| 11/06/2001 | US6313162 Propynyl or dienyl biaromatic compounds |
| 11/06/2001 | US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 11/06/2001 | US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors |
| 11/06/2001 | US6313151 As inhibitors of factor xa and are used as anticoagulants in mammals |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/06/2001 | US6313143 Substituted pyrroles |
| 11/06/2001 | US6313140 Method of treatment using certain growth-hormone secret agogues |
| 11/06/2001 | US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals |
| 11/06/2001 | US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use |
| 11/06/2001 | US6313129 Therapeutic compounds |
| 11/06/2001 | US6313127 For therapy of hypercholesterolemia or atherosclerosis |
| 11/06/2001 | US6313125 Therapeutically active 1,2,4-triazolo[4.,3-B] pyridazine derivatives as ligands for GABA receptors |
| 11/06/2001 | US6313120 Treatment or prevention of diseases involving bradykinin receptors |
| 11/06/2001 | US6313118 Hydroxytryptamine receptor antagonists |
| 11/06/2001 | US6313117 Succinate derivative compounds useful as cysteine protease inhibitors |
| 11/06/2001 | US6313116 Phosphodiesterase inhibitors |
| 11/06/2001 | US6313109 Prenyl transferase inhibitors |
| 11/06/2001 | US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 11/06/2001 | US6312898 Diagnosing and treating subjects having increased risk for the development of the disease using polymerase chain reaction and/or sequencing methods to determine amino acid polymorphism in the protein |
| 11/06/2001 | US6312753 Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses |
| 11/06/2001 | US6312703 Drugs or cosmetics, liquid crystal solids and lecithin |
| 11/06/2001 | US6312693 Antibodies against human CD40 |
| 11/06/2001 | US6312689 Antibodies or antigens |
| 11/06/2001 | US6312688 Tyrosine-phosphatase-related protein |
| 11/06/2001 | US6312686 Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation |